Skip to main content
50°
Rain Shower
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
How Big Are Gilead's Latest COVID Wins?
February 03, 2022
Tickers
GILD
PFE
Tags
Market News
PFE
Recent Press Releases
From
Motley Fool
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
February 02, 2022
Tickers
GILD
GSK
PFE
Tags
GSK
Biotech
Benzinga
From
Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
Tickers
ABBV
ARWR
ATHX
AVIR
Tags
BSX
ARWR
General
From
Benzinga
Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates
February 02, 2022
Tickers
GILD
Tags
Earnings
Dividends
Biotech
From
Benzinga
Gilead Sciences (GILD) Q4 2021 Earnings Call Transcript
February 02, 2022
Tickers
GILD
Tags
GILD
Recent Press Releases
Market News
From
Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 01, 2022
Tickers
AGRX
BFRI
CLSN
ENVB
Tags
CLSN
BFRI
VKTX
From
Benzinga
Gilead earnings slammed by legal settlement, stock falls
February 01, 2022
Tickers
GILD
GSK
PFE
RCUS
Tags
PFE
GSK
RCUS
From
MarketWatch
Gilead Sciences: Q4 Earnings Insights
February 01, 2022
Tickers
GILD
Tags
Market News
Earnings
BZI/Recaps
From
Benzinga
Is AbbVie Stock a Buy Now?
February 01, 2022
Tickers
ABBV
GILD
NVS
SNY
Tags
Market News
Recent Press Releases
NVS
From
Motley Fool
What This FDA News Could Mean for Pfizer
February 01, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
REGN
GILD
LLY
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
Tickers
AGIO
AMYT
ATXI
CTIC
Tags
ATXI
Benzinga
FDA
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
Tickers
ALGN
BMY
CNC
CVS
Tags
BZI/AUOA
Benzinga
MRK
From
Benzinga
How to Invest in Biotech When Deep Value Has no Discernible Meaning
January 31, 2022
Tickers
AMGN
BMY
GILD
Tags
AMGN
GILD
BMY
From
Motley Fool
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
Small Cap
Market News
BNTX
From
Benzinga
Is Gilead Sciences Stock a Buy Now?
January 31, 2022
Tickers
GILD
Tags
GILD
Recent Press Releases
Market News
From
Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
Tickers
BNTX
CURLF
EDIT
GILD
Tags
Market News
BNTX
MSOS
From
Motley Fool
What 5 Analyst Ratings Have To Say About Gilead Sciences
January 28, 2022
Tickers
GILD
Tags
Benzinga
GILD
BZI/AAR
From
Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
Tickers
ABT
BMY
CUE
EW
Tags
MNOV
Penny Stocks
CUE
From
Benzinga
FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings
January 26, 2022
Tickers
GILD
Tags
Market News
FDA
Biotech
From
Benzinga
Why Sierra Oncology Stock Is On Fire Today
January 25, 2022
Tickers
GILD
SRRA
Tags
Recent Press Releases
SRRA
GILD
From
Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Market News
News
Antibodies
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Tickers
ABBV
GILD
HAL
IBM
Tags
Eurozone
A Peek Into The Markets
IPSEY
From
Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
January 24, 2022
Tickers
GILD
Tags
GILD
Benzinga
Health Care
From
Benzinga
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
January 20, 2022
Tickers
BNTX
GILD
LLY
MRK
Tags
MRK
Everest
contributors
From
Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
Tickers
BNTX
GILD
GSK
MRK
Tags
BNTX
GSK
MRK
From
MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
January 20, 2022
Tickers
GILD
MRK
PFE
Tags
MRK
PFE
GILD
From
MarketWatch
Gilead Alleges Counterfeiting Network Sold Fake HIV Drugs
January 19, 2022
Tickers
GILD
Tags
News
HIV treatment
General
From
Benzinga
Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US
January 18, 2022
Tickers
GILD
Tags
Briefs
Market News
FDA
From
Benzinga
3 Pharma Stocks With Especially Juicy Dividends
January 16, 2022
Tickers
ABBV
GILD
PFE
Tags
Recent Press Releases
ABBV
GILD
From
Motley Fool
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
Tickers
GILD
GSK
MRK
VIR
Tags
Recent Press Releases
GILD
Market News
From
Motley Fool
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.